Tumor soluble virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40 ligand

摘要

Exogenous IFN β And exogenous type I FN via one or more heterologous nucleic acid sequences encoding the combination of exogenous CD40 ligand (cd40-l, CD154) β A combination of exogenous cd40-l, e.g., exogenous IFN β Provides an APC such as DC to express the combination of exogenous cd40-l.